Technical note: The serum concentration of the advanced glycation end- product N(ε)-(Carboxymethyl)lysine is increased in uremia

Kidney International

Volumn 52, Issue 4, 1997, Pages 1064-1067

  Degenhardt, Thorsten P ^b   Grass, Linda ^b   Reddy, Sharanya ^b   Thorpe, Suzanne R ^b   Diamandis, Eleftherios P ^b   Baynes, John W ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

Advanced glycation end products; Continuous ambulatory peritoneal dialysis; Hemodialysis; N( ) (carboxymethyl)lysine (CML); Uremia

Indexed keywords

LYSINE DERIVATIVE; N (CARBOXYMETHYL)LYSINE; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; BASEMENT MEMBRANE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GAS CHROMATOGRAPHY; GLYCATION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; UREMIA;

EID: 0030848594     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.429     Document Type: Article

References (26)

1. MCCANCE DR, DYER DG, DUNN JA, BAILIE KE, THORPE SR, BAYNES JW, LYONS TJ Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 91:2470-2478, 1993
2. BEISSWENGER PJ, MOORE LL, BRINCK-JOHNSEN T, CURPHEY TJ: Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy. J Clin Invest 92:212-217, 1993
3. HORIUCHI S: Advanced glycation end products (AGE)-modified proteins and their potential relevance to atherosclerosis. Trends Cardiovasc Med 6:163-168, 1996
4. 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252, 1993
5. ∈-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 50:1303-1309, 1996
6. SMITH MA, TANEDA S, RICHEY PL, MIYATA S, YAN S, STERN D, SAYRE LM, MONNIER VM, PERRY G: Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710-5714, 1994
7. YAN SD, CHEN X, SCHMIDT AM, BRETT J, GODMAN G, ZOU YS, SCOTT CW, CAPUTO C, FRAPPIER T, SMITH MA, PERRY G, YEN S-H, STERN D: Glycated tau-protein in Alzheimer disease: A mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 91:7787-7791, 1994
8. THORPE SR, BAYNES JW: Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 2:69-77, 1996
9. SELL DR, MONNIER VM: Structure elucidation of a senescence cross-link from human extracellular matrix. J Biol Chem 264:21597-21602, 1989
10. DYER DG, BLACKLEDGE JA, THORPE SR, BAYNES JW: Formation of pentosidine during nonenzymatic browning of proteins by glucose. J Biol Chem 266:11654-11660, 1991
11. ∈-(carboxymethyl)lysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4886-4894, 1986
12. DYER DG, DUNN JA, THORPE SR, BAILIE KE, LYONS TJ, MCCANCE DR, BAYNES JW: Accumulation of Maillard reaction products in skin collagen in diabetes and aging. J Clin Invest 91:2463-2469, 1993
13. NAKAYAMA M, KAWAGUCHI Y, YAMADA K, HASEGAWA T, TAKAZOE K, KATOH N, HAYAKAWA H, OSAKA N, YAMAMOTO H, OGAWA A, KUBO H, SHIGEMATSU T, SAKAI O, HORIUCHI S: Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51:182-186, 1997
14. KUME S, TAKEYA M, MORI T, ARAKI N, SUZUKI H, HORIUCHI S, KODAMA T, MIYAUCHI Y, TAKAHASHI K: Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147:654-667, 1995
15. ARAKI N, UENO N, CHAKRABARTI B, MORINO Y, HORIUCHI S: Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214, 1992
16. BUCALA R, MAKITA Z, VEGA G, GRUNDY S, KOSCHINSKY T, CERAMI A, VLASSARA H: Modification of low density lipoprotein by advanced glycation end products contributes to the dysfunction of diabetes and renal insufficiency. Prof Natl Acad Sci USA 91:9441-9445, 1994
17. MAKITA Z, VLASSARA H, CERAMI A, BUCALA R: Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267:5133-5138, 1992
18. TANEDA S, MONNIER VM: ELISA of Pentosidine, an advanced glycation end product, in biological specimens. Clin Chem 40:1766-1773, 1994
19. MENG J, SAKATA N, TAKEBAYASHI S, ASANO T, FUTATA T, ARAKI N, HORIUCHI S: Advanced glycation end products of the Maillard reaction in aortic pepsin-insoluble and pepsin-soluble collagen from diabetic rats. Diabetes 45:1037-1043, 1996
20. BEISSWENGER PJ, MAKITA Z, CURPHEY TJ, MOORE LL, JEAN S, BRINCK-JOHNSEN T, BUCALA R, VLASSARA H: Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824-829, 1995
21. ∈-(Carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue protein. Biochemistry 34:10872-10878, 1995
22. ∈-(Carboxy-methyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. J Biol Chem 35:8075-8083, 1996
23. ∈-(carboxymethyl)lysine (CML), is a product of both lipid peroxidation and glycoxidation reactions. J Biol Chem 271:9982-9986, 1996
24. PAPANASTASIOU P, GRASS L, RODELA H, PATRIKAREA A, OREOPOULOS D, DIAMANDIS EP: Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD. Kidney Int 46:216-222, 1994
25. NAKAYAMA H, TANEDA S, MANDA N, AOKI S, KOMORI K, KURODA Y, MISAWA K, TSUSHIMA S, NAKAGAWA S: Radioimmunoassay for non-enzymatically glycated protein in human serum. Clin Chim Acta 158:293-299, 1986
26. ∈-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 30:1205-1210, 1991